Pharma Journalist -

Gilead Sciences, Inc. and Genesis Therapeutics, Inc. announced that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies…
Read More...

Candid Therapeutics, Inc., a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, announced its official launch. Recent…
Read More...

Get ready for a revolutionary moment in the world of cell therapy as biotech trailblazers, big pharma, and immunology experts from around the globe gather at the 2nd Cell Therapy for…
Read More...

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, announces the completion of a £12.5 million Series B expansion financing bringing the…
Read More...

Moderna, Inc. announced that its manufacturing facility in Laval, Quebec, has been granted a Drug Establishment License (DEL) from Health Canada. This certification affirms the…
Read More...

Vir Biotechnology, Inc. announced that the exclusive worldwide license agreement with Sanofi announced on August 1, 2024, has closed following expiration of the waiting period under the…
Read More...

Amneal Pharmaceuticals, Inc. and Shilpa Medicare Limited announced U.S. Food and Drug Administration (FDA) approval of BORUZU, a new presentation of bortezomib for ready-to-use…
Read More...

NImmune Biopharma, a late-clinical-stage precision immunology biopharmaceutical company that develops novel best-in-class biomarker-driven immunoregulatory therapeutics, announced a…
Read More...

Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr platform to design and develop tunable, precision radiopharmaceuticals for…
Read More...

Evotec SE and X-Chem, leader in DNA-encoded library (DEL) technology, announced a collaboration agreement focused on accelerating early-stage drug discovery. X-Chem’s DEL technology …
Read More...